Olink PEA vs. Mass Spectrometry: A Comparative Analysis of Two Proteomics Methods

In proteomics research, mass spectrometry (MS) and Olink based on PEA (Proximity Extension Assay) technology are two mainstream methods. Each has unique advantages suitable for different research scenarios and goals. This article provides a systematic comparison of the two in terms of technical principles, detection throughput, sensitivity, quantification capabilities, and application scenarios to help researchers choose the most appropriate technical route.

 

1. Core Principles of Mass Spectrometry (MS) and Olink

1. Olink PEA Technology

(1) Based on dual antibody probes binding to target proteins, proximity oligonucleotides generate amplification templates through DNA polymerization;

(2) Uses qPCR or NGS for readout, with detection sensitivity reaching fg/mL;

(3) Achieves high-throughput analysis using predefined panels (up to approximately 3000+ proteins).

 

2. Mass Spectrometry Proteomics

(1) Samples are digested into peptides by proteases and separated and identified using LC-MS/MS;

(2) Does not require antibodies and can theoretically detect thousands of proteins;

(3) Can perform qualitative or quantitative analysis using modes such as DDA (Data Dependent Acquisition), DIA (Data Independent Acquisition), or PRM (Parallel Reaction Monitoring).

 

2. Comparison of Detection Throughput and Coverage Range of Mass Spectrometry (MS) and Olink

1、Olink PEA

(1) Can detect hundreds to 3000+ target proteins in a single run;

(2) Covers common disease-related pathways (inflammation, cancer, metabolism, etc.);

(3) Limited by antibody panels, unable to capture new proteins outside the panel.

 

2. Mass Spectrometry

(1) Theoretical coverage is higher, especially suitable for unbiased full-spectrum exploration;

(2) Requires optimized preprocessing or enrichment for low-abundance, difficult-to-detect proteins;

(3) High-throughput analysis (hundreds of samples) requires longer instrument runtime.

 

3. Sensitivity and Quantification Capabilities of Mass Spectrometry (MS) and Olink

1. Sensitivity

(1) Olink can detect proteins at fg/mL levels, with low-abundance signal detection superior to most conventional mass spectrometry;

(2) Mass spectrometry covers a wide range of high-abundance proteins, but low-abundance proteins require preprocessing enrichment or high-sensitivity platforms.

 

2. Quantification Capabilities

(1) Olink provides relative quantification (NPX value), requiring standard samples to convert to absolute concentration;

(2) Mass spectrometry can achieve absolute quantification through internal standard methods, especially suitable for pharmacokinetic studies or quantitative validation.

 

4. Suitable Research Scenarios for Mass Spectrometry (MS) and Olink

1. Scenarios Suitable for Olink

(1) Large-scale clinical cohort studies (thousands of samples), efficiently detecting predefined protein groups;

(2) Studies requiring low sample volume (1-3 μL) and high repeatability;

(3) Rapid screening of candidate biomarkers.

 

2. Scenarios Suitable for Mass Spectrometry

(1) Discovery research: full-spectrum exploration, identifying new proteins, unknown modifications;

(2) Need for absolute quantification or deep coverage (especially in mechanism research);

(3) Developing personalized targeted detection methods (PRM, MRM).

 

5. Integrated Solutions from Biotech Company

1. Dual Platform Integration

(1) Provides unbiased identification for exploratory research using mass spectrometry;

(2) Combines high-throughput validation with Olink, achieving a complete workflow from biomarker discovery to validation.

 

2. Bioinformatics Support

(1) Provides standardized data processing (NPX calculation, mass spectrometry peak extraction);

(2) Multi-omics integration (transcriptomics, metabolomics) to help researchers quickly obtain publishable results.

 

Olink PEA and mass spectrometry are complementary technologies in proteomics. The former is suitable for large-scale, low sample volume, high-sensitivity, high-throughput research, while the latter excels in full-spectrum exploration, absolute quantification, and targeted validation. Biotech Company combines the advantages of both to provide researchers with a complete process service from exploration to validation, accelerating biomarker research and clinical translation.

 

Biotech Company - A premium service provider in biological product characterization and multi-omics mass spectrometry detection

 

Related Services:

Olink Proteomics